Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
SBI Nifty50 Equal Weight ETF Share Price
Day's Range
Day's Range
Low
₹31.86
High
₹32.28
Price Summary
| Previous Close | ₹32.14 |
|---|---|
| Day's Range | ₹31.86 - ₹32.28 |
| Open | ₹32.28 |
| 52 Week Range | ₹29.64 - ₹35.25 |
| Volume | 11,069 |
| Market Cap |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 3.56 |
|---|---|
| Market Cap (₹ in Mn) | |
| Dividend Yield(%) | |
| Price/Earning (TTM) | |
| TTM EPS (₹) | |
| P/E Ratio | |
| Book Value(₹) | |
| PAT Margin (%) | |
| Face Value (₹) | |
| ROCE(%) |
About SBI Nifty50 Equal Weight ETF
| NSE Symbol | SBINEQWETF |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|
No Records Found
Latest News
Clean Science and Technology inform about resignation of independent director
Ahluwalia Contracts (India) informs about outcome of board meeting
Ahluwalia Contracts (India) has informed about the outcome of the Board Meeting held on May 30, 2026 pursuant to Regulation 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as follows: The Board has, considered and approved the following items among other agenda items: The Statement of Audited Financial Results and Financial Statements (Standalone & Consolidated) of the Company for the Fourth Quarter and Financial Year ended March 31, 2026 along with Auditors Report from Independent Auditors' (SCV & Co., LLP, Chartered Accountants (ICAI Firm Registration No. 000235N/N500089) is enclosed; The Board of Directors have recommended a final dividend at the rate of 35% per equity share (i.e. Re. 0.70 Paisa per share) which shall be subject to approval of the Shareholders at the ensuing Annual General Meeting (AGM) of the Company. The Company shall in due course inform the date on which the Company will hold its AGM for the financial year ended March 31, 2026 and the date from which dividend, if approved by the shareholders, will be paid; Declaration of the Company on the Unmodified Opinion on the Standalone and Consolidated Financial Results/ Statements for the financial year ended March 31, 2026 is enclosed. The Board meeting commenced at 4.00 pm & concluded at 5.15 pm. The above details are also being made available on the Company’s website at www.acilnet.com.
The above information is a part of company’s filings submitted to BSE.
AstraZeneca Pharma India informs about updates
AstraZeneca Pharma India has informed that on June 10, 2026, the company has received permission from the Central Drugs Standard Control Organization, Directorate General of Health Services, Government of India to import for sale and distribution of Trastuzumab deruxtecan 100 mg/5mL vial lyophilized powder for concentrate for solution for infusion (Brand name: Enhertu®) for an additional indication. Through this approval, Trastuzumab deruxtecan in combination with pertuzumab is indicated for the first-line treatment of adult patients with unresectable or metastatic HER2-positive (IHC3+ or ISH+) breast cancer. The receipt of this permission paves way for the marketing of Trastuzumab deruxtecan 100 mg/5mL vial lyophilized powder for concentrate for solution for infusion (Brand name: Enhertu®) in India for the specified additional indication, subject to the receipt of related statutory approvals, if any.
The above information is a part of company’s filings submitted to BSE.
Aspira Pathlab & Diagnostics informs about updates
Gokul Refoils & Solvent informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of SBI Nifty50 Equal Weight ETF is ₹32.14 as of 2026-06-11.
The market capitalisation of SBI Nifty50 Equal Weight ETF is ₹ as of .
The 1-year return of SBI Nifty50 Equal Weight ETF is 0.02% as of 2026-06-11.
The P/E ratio of SBI Nifty50 Equal Weight ETF is as of .
The 52-week high and low of SBI Nifty50 Equal Weight ETF are ₹ and ₹, respectively, as of 2026-06-11.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
